News

Dexamethasone sodium phosphate injection, a synthetic adrenocortical steroid anti-inflammatory drug, is used by intravenous or intramuscular injection when oral therapy is not feasible and indicated for endocrine, rheumatic

CoFactor is the company’s biomodulator designed to enhance the activity of the widely used cancer drug 5-fluorouracil (5-FU). The US phase III pivotal clinical trial will be a

The multi-center, blinded, placebo controlled trial will be conducted in 50 cystic fibrosis (CF) centers in the US, and will evaluate the efficacy and safety of aztreonam lysinate

The office will employ in the region 30 to 40 people by the end of 2006, with research activities related to clinical R&D also managed from Ireland. The

Under the agreement, Aspen will manufacture Gilead’s antiretroviral (ARV) products Truvada (emtricitabine and tenofovir disoproxil fumarate) and Viread (tenofovir disoproxil fumarate) for the 95 resource-limited countries included in

The trial is in patients with either advanced bronchioloalveolar carcinoma (BAC) or adenocarcinoma with BAC features that have progressed on or after receiving one to two lines of

The phase III psoriasis trial, named SPIRIT, which commenced in December 2004, includes a total of 453 patients with stable moderate to severe plaque psoriasis. The trial is

According to the company, this novel small molecule anticancer compound potently inhibits receptor tyrosine kinases (RTKs) implicated in tumor proliferation and vascularization. XL820 is the fifth compound to

The agreement is Bentley’s first to develop and license its intranasal spray formulation of insulin. Under the agreement, the two companies have agreed to conduct phase II and